The event will include an industry overview followed by a showcase of several exciting up-and-coming start-ups in the
Myopia sector, a deep-dive panel discussion with industry executives and a live Q&A with select presenting companies.
Throughout the event you will have the ability to ask questions and network with other attendees in real time.
AGENDA | APRIL 29 | 1:00 PM EDT
1:00 - 1:05 PM EDT
Welcome & Opening Remarks
1:05 - 1:20 PM EDT
Myopia Market Overview
1:20 - 2:25 PM EDT
2:25 - 3:10 PM EDT
Myopia Management - Clinical Perspective
3:10 - 4:00 PM EDT
Myopia Management - Industry Perspective
4:00 - 4:05 PM EDT
4:05 - 5:00 PM EDT
PROUDLY SPONSORED BY:
Bausch + Lomb
Bausch + Lomb, a wholly owned subsidiary of Bausch Health Companies, is one of the world's best-known and most respected health care brands, solely focused on protecting, enhancing and restoring people's eyesight.
Alcon, the global leader in eye care, provides innovative products that enhance quality of life by helping people worldwide see better. Through Surgical, Pharmaceutical and Vision Care, Alcon offers the world’s widest spectrum of ophthalmic products, helping millions of patients see the world better with clarity, color and beauty.
Novartis is a leading ophthalmology company, with therapies that treat both front and back of the eye disorders, including retina diseases, glaucoma, dry eye and other external eye diseases. In 2016, approximately 200 million patients worldwide were treated with Novartis ophthalmic products.
Promedica International is a privately held, full-service, ISO-certified CRO providing clinical trial services for the medical device, biotechnology and pharmaceutical industries. Founded in 1985, Promedica International, a woman-owned corporation, is headquartered in Orange County, California. We have successfully been providing exceptional value to our clients for over 30 years in clinical trial project management, site recruitment and management, clinical study monitoring, data management, biostatistics, medical writing and GCP auditing.
CooperVision, a division of CooperCompanies (NYSE:COO), is one of the world’s leading manufacturers of contact lenses. The company produces a full array of daily disposable, two-week and monthly soft contact lenses that feature advanced materials and optics, and premium rigid gas permeable lenses for orthokeratology and scleral designs. CooperVision has a strong heritage of addressing the toughest vision challenges such as astigmatism, presbyopia, childhood myopia, and highly irregular corneas; and offers the most complete portfolio of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers.